Meyka Pro banner
Cardinal Health, Inc.

Cardinal Health, Inc. Fundamental Analysis (NYSE: CAH)

CAHNYSE
HealthcareMedical - Distribution
$229.51
$5.34(2.27%)
U.S. Market opens in 64h 50m

Cardinal Health, Inc. Fundamental Analysis (NYSE: CAH)

Cardinal Health, Inc. (NYSE: CAH) shows weak financial fundamentals with a PE ratio of 31.69, profit margin of 0.67%, and ROE of -59.73%. The company generates $252.3B in annual revenue with weak year-over-year growth of -1.87%.

Key Strengths

No significant strengths identified.

Areas of Concern

ROE-59.73%
Operating Margin1.03%
PEG Ratio2.56
Current Ratio0.88
We analyze CAH's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 12.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
12.8/100

We analyze CAH's fundamental strength across five key dimensions:

Efficiency Score

Weak

CAH struggles to generate sufficient returns from assets.

ROA > 10%
2.99%

Valuation Score

Weak

CAH trades at a premium to fair value.

PE < 25
31.69
PEG Ratio < 2
2.56

Growth Score

Moderate

CAH shows steady but slowing expansion.

Revenue Growth > 5%
-1.87%
EPS Growth > 10%
86.21%

Financial Health Score

Moderate

CAH shows balanced financial health with some risks.

Debt/Equity < 1
-3.45
Current Ratio > 1
0.88

Profitability Score

Weak

CAH struggles to sustain strong margins.

ROE > 15%
-5973.17%
Net Margin ≥ 15%
0.67%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CAH Expensive or Cheap?

P/E Ratio

CAH trades at 31.69 times earnings. This suggests a premium valuation.

31.69

PEG Ratio

When adjusting for growth, CAH's PEG of 2.56 indicates potential overvaluation.

2.56

Price to Book

The market values Cardinal Health, Inc. at -18.86 times its book value. This may indicate undervaluation.

-18.86

EV/EBITDA

Enterprise value stands at 14.05 times EBITDA. This signals the market has high growth expectations.

14.05

How Well Does CAH Make Money?

Net Profit Margin

For every $100 in sales, Cardinal Health, Inc. keeps $0.67 as profit after all expenses.

0.67%

Operating Margin

Core operations generate 1.03 in profit for every $100 in revenue, before interest and taxes.

1.03%

ROE

Management delivers $-59.73 in profit for every $100 of shareholder equity.

-59.73%

ROA

Cardinal Health, Inc. generates $2.99 in profit for every $100 in assets, demonstrating efficient asset deployment.

2.99%

Following the Money - Real Cash Generation

Operating Cash Flow

Cardinal Health, Inc. generates limited operating cash flow of $5.13B, signaling weaker underlying cash strength.

$5.13B

Free Cash Flow

Cardinal Health, Inc. generates weak or negative free cash flow of $4.49B, restricting financial flexibility.

$4.49B

FCF Per Share

Each share generates $19.17 in free cash annually.

$19.17

FCF Yield

CAH converts 8.40% of its market value into free cash.

8.40%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

31.69

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

2.56

vs 25 benchmark

P/B Ratio

Price to book value ratio

-18.86

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.21

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-3.45

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.88

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.60

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

0.20

vs 25 benchmark

How CAH Stacks Against Its Sector Peers

MetricCAH ValueSector AveragePerformance
P/E Ratio31.6931.19 Neutral
ROE-59.73%447.00% Weak
Net Margin0.67%21592.00% Weak
Debt/Equity-3.450.54 Strong (Low Leverage)
Current Ratio0.885.66 Weak Liquidity
ROA2.99%-52.00% (disorted) Weak

CAH outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cardinal Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

76.96%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

151.39%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

48.68%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ